US-based Perrigo, a global healthcare manufacturer and supplier of OTC products, has acquired Galpharm Healthcare for $86 million in cash.
Subscribe to our email newsletter
The acquisition is expected to add more than $55 million in sales annually and be accretive to earnings in the first year.
Joseph Papa, chairman and CEO of Perrigo, said: “The acquisition of Galpharm further expands our global presence, complements our existing UK business and increases value for our shareholders. It also helps us meet the world’s growing need for quality, affordable healthcare.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.